Infection par le Virus de la grippe aviaire ou d'une autre origine animale

Nanoparticle vaccine offers better protection: Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

Undefined

European prices reapply old pressures to vaccine makers

The vaccine sector appears to be in good health. After coming through a period in which low profit margins and liability concerns deterred investment, EvaluatePharma now tips the sector to grow from $25 billion to $39 billion between 2012 and 2018. Yet, in some areas, old complaints can still be heard.

Undefined

NIH trialing Sanofi H7N9 vaccine with GSK, Novartis adjuvants

Delivering a vaccine against an emerging pandemic flu strain requires developers to make a lot of quick decisions about dosing, use of adjuvants and other factors. With H7N9, however, China's success in limiting the virus' spread has given other countries more time to prepare.

Undefined

Genomic test can distinguish between bacterial and viral infections

A blood test developed by Duke Medicine researchers was more than 90 percent accurate when distinguishing between viral and bacterial respiratory infections, according to a study published on Wednesday in Science Translational Medicine.

Undefined

The FLUgitives Campaign Encourages More Americans to Get Their Annual Flu Shot

This national campaign rounds up #FLUgitives, people who have not been vaccinated against the flu yet this season, and encourages them to turn themselves in to their healthcare provider to learn more about the seriousness of influenza and their available vaccine options. One option is Fluzone® Intradermal vaccine, which uses a next-generation device with a tiny needle to quickly deliver flu vaccine just under the skin’s surface.
 
Read the rest of the release here.

Undefined

Two more H5N1 cases confirmed

A 5-year-old girl from Takeo province and a 2-year-old girl from Kampot province – who has already died – mark the 19th and 20th confirmed cases of avian influenza this year, a hospital spokesman said.

“The 2-year-old from Kampot was in very serious condition when she arrived and died yesterday after only two days in hospital,” said Dr Denis Laurent, a spokesman for Kantha Bopha Hospital in Phnom Penh.

Read the rest of the article here.

Undefined

Bird flu viruses could re-emerge in upcoming flu season

FAO has issued a new warning to the international community that the H7N9 and H5N1 avian influenza viruses continue to pose serious threats to human and animal health, especially in view of the upcoming flu season.

Undefined

Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE)

The Strategic Advisory Group of Experts (SAGE) on Immunization was established by the Director-General of the World Health Organization in 1999 to provide guidance on the work of the WHO Immunization, Vaccines and Biologicals Department. SAGE is the principal advisory group to WHO for vaccines and immunization. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases.
Undefined

Pain-Free Microneedle Influenza Vaccine Is Effective, Long-Lasting

Pain-Free Microneedle Influenza Vaccine Is Effective, Long-Lasting

 

September 4, 2013 -- Scientists have developed an influenza vaccine delivered via microneedle patch that provided 100 percent protection against a lethal influenza virus in mice more than one year after vaccination. They report their findings in the September 2013 issue of the journal Clinical and Vaccine Immunology.

Undefined

Pages